Limited Effects of UV-A1 Phototherapy in 3 Patients With Nephrogenic Systemic Fibrosis

Kreuter, Alexander; Gambichler, Thilo; Weiner, Stefan M.; Schieren, Gisela

doi:10.1001/archderm.144.11.1527

Cited by 20 publications

(9 citation statements)

References 5 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Plasmapheresis, cyclophosphamide, and prednisone alone and in combination with MTX have been utilized with limited success [28]. UVA light therapy and PUVA have yielded very mild improvement [29]. One somewhat more promising therapy is the use of imatinib mesylate.…”

Section: Treatment and Prognosismentioning

confidence: 99%

Scleroderma Mimics

Nashel

Steen

2011

Curr Rheumatol Rep

View full text Add to dashboard Cite

Scleroderma is a rare systemic autoimmune disease with multiple organ manifestations, including skin fibrosis. The groups of disorders classified as scleroderma mimics share the common thread of skin thickening but are otherwise quite incongruous in terms of underlying disease process and other organ involvement. This article reviews the clinical presentation, etiology, and treatment options available for scleroderma mimics, including morphea, scleredema, diabetic cheiroarthropathy, scleromyxedema, nephrogenic systemic fibrosis, and eosinophilic fasciitis. Through greater understanding of these diseases and the associated extradermal implications, we hope to facilitate recognition of scleroderma and its mimics.

show abstract

Section: Treatment and Prognosismentioning

confidence: 99%

Scleroderma Mimics

Nashel

Steen

2011

Curr Rheumatol Rep

View full text Add to dashboard Cite

show abstract

“…Recently, low-dose UV-A1 failed to significantly improve three patients [44], whereas the combination of retinoid and psoralens and ultraviolet A (PUVA) treatment has been reported to partially improve two patients [45]. Three patients were treated with sodium thiosulphate shortly after the beginning of the disease and seemed to improve [46 ].…”

Section: Treatmentmentioning

confidence: 99%

Nephrogenic systemic fibrosis

Bardin

Richette

2010

Current Opinion in Rheumatology

View full text Add to dashboard Cite

show abstract

“…Three patients were treated with low-dose ultraviolet A1 phototherapy (88-101 cycles) with very limited effects. 4 Extracorporal photopheresis was started in two patients only recently, as a beneficial effect in NSF has been described in the literature. 5 Because of age, poor physical condition, or refusal of therapy, 5 patients received no treatment, yet disease progression did not appear to be accelerated in comparison with treated patients.…”

Section: Impact Of Different Therapeutic Approaches On Disease Progrementioning

confidence: 99%